Key Takeaways
- • Blackstone stock has declined approximately 40.7% ($76.74 per share) from its 52-week high of $190.09, currently trading near $124.61 as of the latest session, representing a valuation compression despite strong operational performance.
- • The company beat Q1 earnings per share estimates at $1.36, yet the stock experienced a sharp 6.24% single-session decline, reflecting a significant disconnect between fundamental results and market valuation.
- • A consensus of 26 analysts maintains a "Buy" rating with a 2026 price target of $157.27, though individual targets range widely from $156.88 to $195, indicating mixed conviction amid market uncertainty.
- • Private credit headwinds have emerged as a key pressure point, with redemption requests at Blackstone's $82 billion direct lending fund (BCRED) and broader re-rating concerns affecting investor sentiment toward alternative asset managers.
- • Historical earnings growth of 30% annually over three years contrasts sharply with only 7% annual stock price appreciation, highlighting persistent valuation compression despite operational execution.
Summary
Blackstone Inc. (NYSE: BX) faces a significant valuation disconnect as the world's largest alternative asset manager trades substantially below historical highs, down approximately 40.7% from its 52-week peak of $190.09. The stock recently closed at $124.61, representing a sharp $76.74 decline per share and reflecting broader market skepticism toward the alternative investment sector despite the company's strong operational fundamentals.
The selloff has intensified despite the company's Q1 earnings beat, with the stock experiencing a sharp 6.24% single-session decline that underscores investor concerns extending beyond quarterly results. Analysis indicates two converging pressures driving the weakness: a private credit panic triggered by rising redemption requests at BCRED, Blackstone's $82 billion direct lending fund targeting individual investors, and a sector-wide re-rating as institutional investors question valuation multiples across alternative asset managers.
The fundamental-to-valuation mismatch has become pronounced. The company has delivered 30% annualized earnings-per-share growth over three years, yet the stock price has appreciated only 7% annually during the same period. This divergence has prompted analyst commentary characterizing Blackstone as underperforming the broader market while fundamentals remain solid.
The analyst community maintains cautious optimism. A consensus of 26 analysts rates the stock as a "Buy" with a 2026 price target of $157.27, implying approximately 26% upside from current levels. However, individual price targets range from $156.88 to $195, with Citizens issuing the high target on January 30, 2026, indicating divergent views on valuation recovery timing and magnitude. Institutional investors face a decision between viewing current levels as a compelling entry point given operational performance or waiting for clarity on private credit redemption pressures and sector re-rating dynamics.
The selloff has intensified despite the company's Q1 earnings beat, with the stock experiencing a sharp 6.24% single-session decline that underscores investor concerns extending beyond quarterly results. Analysis indicates two converging pressures driving the weakness: a private credit panic triggered by rising redemption requests at BCRED, Blackstone's $82 billion direct lending fund targeting individual investors, and a sector-wide re-rating as institutional investors question valuation multiples across alternative asset managers.
The fundamental-to-valuation mismatch has become pronounced. The company has delivered 30% annualized earnings-per-share growth over three years, yet the stock price has appreciated only 7% annually during the same period. This divergence has prompted analyst commentary characterizing Blackstone as underperforming the broader market while fundamentals remain solid.
The analyst community maintains cautious optimism. A consensus of 26 analysts rates the stock as a "Buy" with a 2026 price target of $157.27, implying approximately 26% upside from current levels. However, individual price targets range from $156.88 to $195, with Citizens issuing the high target on January 30, 2026, indicating divergent views on valuation recovery timing and magnitude. Institutional investors face a decision between viewing current levels as a compelling entry point given operational performance or waiting for clarity on private credit redemption pressures and sector re-rating dynamics.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.